Barclays Reiterates an 'Overweight' on ARIAD Pharmaceuticals (ARIA); Ponatinib Demonstrated Acceptable Safety Profile
Go back to Barclays Reiterates an 'Overweight' on ARIAD Pharmaceuticals (ARIA); Ponatinib Demonstrated Acceptable Safety Profile| Ariad Pharmaceuticals, Inc. (NYSE: ARIA) | Delayed: 24.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.94 | 52 Week High | $14.34 | |||
| Open | $24.94 | 52 Week Low | $4.37 | |||
| Day High | $24.94 | P/E | N/A | |||
| Day Low | $24.94 | EPS | $-1.45 | |||
| Volume | 8 | |||||

